Cantor Fitzgerald Upgrades 4D Molecular Therapeutics (FDMT) to Overweight

September 14, 2026 6:37 AM

(Updated - September 14, 2026 6:49 AM EDT)

Cantor Fitzgerald analyst Joshua Schimmer upgraded 4D Molecular Therapeutics (NASDAQ: FDMT) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found